Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
Identifieur interne : 000815 ( Main/Exploration ); précédent : 000814; suivant : 000816Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
Auteurs : Aimé Bonny [Cameroun] ; Mohammed A. Talle [Nigeria] ; Marcus Ngantcha [Cameroun] ; Muzahir H. Tayebjee [Royaume-Uni]Source :
- Travel medicine and infectious disease [ 1873-0442 ]
Descripteurs français
- KwdFr :
- MESH :
- traitement médicamenteux : Infections à coronavirus.
- usage thérapeutique : Azithromycine, Hydroxychloroquine.
- Betacoronavirus, France, Humains, Pandémies, Pneumopathie virale, Études rétrospectives.
- Wicri :
- geographic : France.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Azithromycin, Hydroxychloroquine.
- geographic : France.
- drug therapy : Coronavirus Infections.
- Betacoronavirus, COVID-19, Humans, Pandemics, Pneumonia, Viral, Retrospective Studies, SARS-CoV-2.
DOI: 10.1016/j.tmaid.2020.101861
PubMed: 32889105
PubMed Central: PMC7462460
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".</title><author><name sortKey="Bonny, Aime" sort="Bonny, Aime" uniqKey="Bonny A" first="Aimé" last="Bonny">Aimé Bonny</name><affiliation wicri:level="1"><nlm:affiliation>Faculty of medicine and pharmaceutical sciences, University of Douala, Cameroon. Electronic address: aimebonny@yahoo.fr.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Faculty of medicine and pharmaceutical sciences, University of Douala</wicri:regionArea><wicri:noRegion>University of Douala</wicri:noRegion></affiliation></author><author><name sortKey="Talle, Mohammed A" sort="Talle, Mohammed A" uniqKey="Talle M" first="Mohammed A" last="Talle">Mohammed A. Talle</name><affiliation wicri:level="1"><nlm:affiliation>Maiduguri Teaching Hospital, Maiduguri, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Maiduguri Teaching Hospital, Maiduguri</wicri:regionArea><wicri:noRegion>Maiduguri</wicri:noRegion></affiliation></author><author><name sortKey="Ngantcha, Marcus" sort="Ngantcha, Marcus" uniqKey="Ngantcha M" first="Marcus" last="Ngantcha">Marcus Ngantcha</name><affiliation wicri:level="1"><nlm:affiliation>Homeland Heart Centre, Bonamoussadi, Douala, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Homeland Heart Centre, Bonamoussadi, Douala</wicri:regionArea><wicri:noRegion>Douala</wicri:noRegion></affiliation></author><author><name sortKey="Tayebjee, Muzahir H" sort="Tayebjee, Muzahir H" uniqKey="Tayebjee M" first="Muzahir H" last="Tayebjee">Muzahir H. Tayebjee</name><affiliation wicri:level="1"><nlm:affiliation>Leeds Teaching Hospitals NHS Trust, Leeds, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Leeds Teaching Hospitals NHS Trust, Leeds</wicri:regionArea><wicri:noRegion>Leeds</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020 Sep - Oct</date><idno type="RBID">pubmed:32889105</idno><idno type="pmid">32889105</idno><idno type="doi">10.1016/j.tmaid.2020.101861</idno><idno type="pmc">PMC7462460</idno><idno type="wicri:Area/Main/Corpus">000C87</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C87</idno><idno type="wicri:Area/Main/Curation">000C87</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000C87</idno><idno type="wicri:Area/Main/Exploration">000C87</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".</title><author><name sortKey="Bonny, Aime" sort="Bonny, Aime" uniqKey="Bonny A" first="Aimé" last="Bonny">Aimé Bonny</name><affiliation wicri:level="1"><nlm:affiliation>Faculty of medicine and pharmaceutical sciences, University of Douala, Cameroon. Electronic address: aimebonny@yahoo.fr.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Faculty of medicine and pharmaceutical sciences, University of Douala</wicri:regionArea><wicri:noRegion>University of Douala</wicri:noRegion></affiliation></author><author><name sortKey="Talle, Mohammed A" sort="Talle, Mohammed A" uniqKey="Talle M" first="Mohammed A" last="Talle">Mohammed A. Talle</name><affiliation wicri:level="1"><nlm:affiliation>Maiduguri Teaching Hospital, Maiduguri, Nigeria.</nlm:affiliation><country xml:lang="fr">Nigeria</country><wicri:regionArea>Maiduguri Teaching Hospital, Maiduguri</wicri:regionArea><wicri:noRegion>Maiduguri</wicri:noRegion></affiliation></author><author><name sortKey="Ngantcha, Marcus" sort="Ngantcha, Marcus" uniqKey="Ngantcha M" first="Marcus" last="Ngantcha">Marcus Ngantcha</name><affiliation wicri:level="1"><nlm:affiliation>Homeland Heart Centre, Bonamoussadi, Douala, Cameroon.</nlm:affiliation><country xml:lang="fr">Cameroun</country><wicri:regionArea>Homeland Heart Centre, Bonamoussadi, Douala</wicri:regionArea><wicri:noRegion>Douala</wicri:noRegion></affiliation></author><author><name sortKey="Tayebjee, Muzahir H" sort="Tayebjee, Muzahir H" uniqKey="Tayebjee M" first="Muzahir H" last="Tayebjee">Muzahir H. Tayebjee</name><affiliation wicri:level="1"><nlm:affiliation>Leeds Teaching Hospitals NHS Trust, Leeds, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Leeds Teaching Hospitals NHS Trust, Leeds</wicri:regionArea><wicri:noRegion>Leeds</wicri:noRegion></affiliation></author></analytic><series><title level="j">Travel medicine and infectious disease</title><idno type="eISSN">1873-0442</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Azithromycin (therapeutic use)</term><term>Betacoronavirus (MeSH)</term><term>COVID-19 (MeSH)</term><term>Coronavirus Infections (drug therapy)</term><term>France (MeSH)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (MeSH)</term><term>Retrospective Studies (MeSH)</term><term>SARS-CoV-2 (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Azithromycine (usage thérapeutique)</term><term>Betacoronavirus (MeSH)</term><term>France (MeSH)</term><term>Humains (MeSH)</term><term>Hydroxychloroquine (usage thérapeutique)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (MeSH)</term><term>Études rétrospectives (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Azithromycin</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Azithromycine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>COVID-19</term><term>Humans</term><term>Pandemics</term><term>Pneumonia, Viral</term><term>Retrospective Studies</term><term>SARS-CoV-2</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term><term>France</term><term>Humains</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Études rétrospectives</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">32889105</PMID><DateCompleted><Year>2020</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-0442</ISSN><JournalIssue CitedMedium="Internet"><Volume>37</Volume><PubDate><MedlineDate>2020 Sep - Oct</MedlineDate></PubDate></JournalIssue><Title>Travel medicine and infectious disease</Title><ISOAbbreviation>Travel Med Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".</ArticleTitle><Pagination><MedlinePgn>101861</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1477-8939(20)30357-4</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tmaid.2020.101861</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bonny</LastName><ForeName>Aimé</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of medicine and pharmaceutical sciences, University of Douala, Cameroon. Electronic address: aimebonny@yahoo.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talle</LastName><ForeName>Mohammed A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Maiduguri Teaching Hospital, Maiduguri, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngantcha</LastName><ForeName>Marcus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Homeland Heart Centre, Bonamoussadi, Douala, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tayebjee</LastName><ForeName>Muzahir H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Leeds Teaching Hospitals NHS Trust, Leeds, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Travel Med Infect Dis</MedlineTA><NlmUniqueID>101230758</NlmUniqueID><ISSNLinking>1477-8939</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>83905-01-5</RegistryNumber><NameOfSubstance UI="D017963">Azithromycin</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Travel Med Infect Dis. 2020 May - Jun;35:101738</RefSource><PMID Version="1">32387409</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D017963" MajorTopicYN="N">Azithromycin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="Y">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>05</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>08</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>12</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32889105</ArticleId><ArticleId IdType="pii">S1477-8939(20)30357-4</ArticleId><ArticleId IdType="doi">10.1016/j.tmaid.2020.101861</ArticleId><ArticleId IdType="pmc">PMC7462460</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>JAMA. 2020 May 26;323(20):2052-2059</Citation><ArticleIdList><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Travel Med Infect Dis. 2020 May - Jun;35:101735</Citation><ArticleIdList><ArticleId IdType="pubmed">32387694</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiovasc J Afr. 2018 Mar/Apr;29(2):115-121</Citation><ArticleIdList><ArticleId IdType="pubmed">29745966</ArticleId></ArticleIdList></Reference><Reference><Citation>Travel Med Infect Dis. 2020 May - Jun;35:101738</Citation><ArticleIdList><ArticleId IdType="pubmed">32387409</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 May 12;323(18):1775-1776</Citation><ArticleIdList><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA Cardiol. 2020 Sep 1;5(9):1036-1041</Citation><ArticleIdList><ArticleId IdType="pubmed">32936252</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Infect Dis. 2020 Jun;20(6):630-631</Citation><ArticleIdList><ArticleId IdType="pubmed">32240633</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Cameroun</li><li>Nigeria</li><li>Royaume-Uni</li></country></list><tree><country name="Cameroun"><noRegion><name sortKey="Bonny, Aime" sort="Bonny, Aime" uniqKey="Bonny A" first="Aimé" last="Bonny">Aimé Bonny</name></noRegion><name sortKey="Ngantcha, Marcus" sort="Ngantcha, Marcus" uniqKey="Ngantcha M" first="Marcus" last="Ngantcha">Marcus Ngantcha</name></country><country name="Nigeria"><noRegion><name sortKey="Talle, Mohammed A" sort="Talle, Mohammed A" uniqKey="Talle M" first="Mohammed A" last="Talle">Mohammed A. Talle</name></noRegion></country><country name="Royaume-Uni"><noRegion><name sortKey="Tayebjee, Muzahir H" sort="Tayebjee, Muzahir H" uniqKey="Tayebjee M" first="Muzahir H" last="Tayebjee">Muzahir H. Tayebjee</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000815 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000815 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32889105
|texte= Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32889105" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |